Please login to the form below

Not currently logged in
Email:
Password:

Boehringer names Ross Ullman as US consumer marketing director

His responsibilities will include developing the Zantac and Dulcolax brand visions

Ross Ullman has joined Boehringer Ingelheim's US operations as executive director, marketing for its consumer healthcare division.

He will be responsible for developing the Zantac and Dulcolax brand visions as part of a remit that includes annual planning, advertising and media development, brand innovation strategies and new product development.

“This is a position that is pivotal to Boehringer Ingelheim's continued success in the heartburn and constipation areas of our business, and we are proud to add Ross to our team,” said Marc Rovner, vice president and general manager, Consumer HealthCare Products.

“Through his vision and past successes, we are confident that Ross can help take Zantac and Dulcolax to the next level.”

Ullman joins the pharma company from Reckitt Benckiser, where he spent 14 years, most recently as marketing director for is $850m Lysol franchise.

During his time with the company he spearheaded Reckitt Benckiser's first ever social marketing brand platform, leveraging Facebook, bloggers and targeted community social sites to strengthen consumer engagement and sales.

“The players are different but the basics of marketing remain the same,” Ross said. “Now I'm getting a thorough education about the OTC universe and what motivates consumers in this industry. These are strong brands with great growth potential. My job now is simply to help deliver that growth.”

29th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics